首页> 外文期刊>Journal of Agricultural and Food Chemistry >Anti-diabetic Effects of Monascus purpureus NTU 568 Fermented Products on Streptozotocin-lnduced Diabetic Rats
【24h】

Anti-diabetic Effects of Monascus purpureus NTU 568 Fermented Products on Streptozotocin-lnduced Diabetic Rats

机译:红曲霉NTU 568发酵产物对链脲佐菌素诱导的糖尿病大鼠的抗糖尿病作用

获取原文
获取原文并翻译 | 示例
       

摘要

Red-mold-fermented products have the unique ability to economically produce many secondary metabolites and are known to improve blood circulation. Diabetes mellitus is a chronic disease that is characterized by hyperglycemia caused by insufficient insulin action. In the current study, we examine the effect of Monascus purpureus NTU 568 fermented products on fasting blood glucose and oral glucose tolerance testing (OGTT) in streptozotocin-induced diabetic rats. After 8 weeks of being fed with red-mold-fermented products at a dose of 200 mg/kg, the experimental results indicate that oral administration of red-mold-fermented products can delay the development of the plasma glucose level in rats. A significant reduction was found in urine sugar and urine protein levels. The study scientifically validates the widely claimed use of red-mold-fermented products as an ethnomedicine to treat diabetes mellitus.
机译:红霉菌发酵的产品具有经济地生产许多次生代谢产物的独特能力,并且已知能改善血液循环。糖尿病是一种慢性疾病,其特征是胰岛素作用不足引起的高血糖症。在当前的研究中,我们研究了红曲霉NTU 568发酵产品对链脲佐菌素诱发的糖尿病大鼠的空腹血糖和口服葡萄糖耐量测试(OGTT)的影响。用200 mg / kg剂量的红霉菌发酵食品喂食8周后,实验结果表明,口服红霉菌发酵产品可以延缓大鼠血浆葡萄糖水平的发展。发现尿糖和尿蛋白水平显着降低。这项研究科学地证实了广泛认可的使用红霉菌发酵产品作为治疗糖尿病的民族药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号